Literature DB >> 18024075

Hyperglycaemia inhibits Schwann cell proliferation and migration and restricts regeneration of axons and Schwann cells from adult murine DRG.

Laura F Gumy1, Edward T W Bampton, Aviva M Tolkovsky.   

Abstract

Poorly-controlled hyperglycaemia reduces peripheral nerve regeneration in diabetes through ill-understood mechanisms. Apoptosis is one proposed primary response. We examined how hyperglycaemia affects regeneration of axons and Schwann cells (SC) from cultured adult mouse Dorsal Root Ganglia (DRG) to separate cell-autonomous responses from systemic influences. Hyperglycaemia reduced neurite growth rate by 20-30% without altering growth cone density, indicating neuronal apoptosis was negligible. Moderate hyperglycaemia also profoundly retarded SC migration from DRG explants. This effect was independent of neuritogenesis and was reversible, indicating that SC had not died. In purified SC, even mild hyperglycaemia inhibited neuregulin-beta1-induced bromodeoxyuridine-incorporation and phosphorylation of retinoblastoma protein, indicating a block at the G1-S boundary. Moreover, migration of purified SC was inhibited by >90%. Thus, SC proliferation and migration, and axon regeneration from DRG neurons, are impaired by hyperglycaemia cell autonomously, while apoptosis is negligible. Impairment of these functions over time may exacerbate nerve injury-related diabetic neuropathy.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18024075     DOI: 10.1016/j.mcn.2007.10.004

Source DB:  PubMed          Journal:  Mol Cell Neurosci        ISSN: 1044-7431            Impact factor:   4.314


  55 in total

1.  Mitochondrial stress and the pathogenesis of diabetic neuropathy.

Authors:  Paul Fernyhough; Subir K Roy Chowdhury; Robert E Schmidt
Journal:  Expert Rev Endocrinol Metab       Date:  2010-01-01

2.  Effects of High Glucose on Cell Viability and Differentiation in Primary Cultured Schwann Cells: Potential Role of ERK Signaling Pathway.

Authors:  Di Liu; Xiaochun Liang; Hong Zhang
Journal:  Neurochem Res       Date:  2016-02-25       Impact factor: 3.996

3.  Phosphodiesterase-5 is a therapeutic target for peripheral neuropathy in diabetic mice.

Authors:  L Wang; M Chopp; A Szalad; Z Liu; M Bolz; F M Alvarez; M Lu; L Zhang; Y Cui; R L Zhang; Z G Zhang
Journal:  Neuroscience       Date:  2011-07-27       Impact factor: 3.590

4.  Puerarin may protect against Schwann cell damage induced by glucose fluctuation.

Authors:  Bing Xue; Lin Wang; Zhe Zhang; Rui Wang; Xin-Xin Xia; Ping-Ping Han; Li-Jun Cao; Yong-Hui Liu; Lian-Qing Sun
Journal:  J Nat Med       Date:  2017-02-08       Impact factor: 2.343

5.  Embryonic cell migratory capacity is impaired upon exposure to glucose in vivo and in vitro.

Authors:  Nils Janis Herion; Claudia Kruger; Jaroslaw Staszkiewicz; Claudia Kappen; J Michael Salbaum
Journal:  Birth Defects Res       Date:  2018-11-19       Impact factor: 2.344

6.  Dyslipidemia impairs mitochondrial trafficking and function in sensory neurons.

Authors:  Amy E Rumora; Stephen I Lentz; Lucy M Hinder; Samuel W Jackson; Andrew Valesano; Gideon E Levinson; Eva L Feldman
Journal:  FASEB J       Date:  2017-09-13       Impact factor: 5.191

7.  A brief review of in vitro models of diabetic neuropathy.

Authors:  Namita G Hattangady; Medha S Rajadhyaksha
Journal:  Int J Diabetes Dev Ctries       Date:  2009-10

8.  Molecular control of Schwann cell migration along peripheral axons: keep moving!

Authors:  Stephan Heermann; Markus H Schwab
Journal:  Cell Adh Migr       Date:  2012-10-17       Impact factor: 3.405

9.  Development of selective axonopathy in adult sensory neurons isolated from diabetic rats: role of glucose-induced oxidative stress.

Authors:  Elena Zherebitskaya; Eli Akude; Darrell R Smith; Paul Fernyhough
Journal:  Diabetes       Date:  2009-02-27       Impact factor: 9.461

10.  Structural and ultrastructural analysis of cerebral cortex, cerebellum, and hypothalamus from diabetic rats.

Authors:  Juan P Hernández-Fonseca; Jaimar Rincón; Adriana Pedreañez; Ninoska Viera; José L Arcaya; Edgardo Carrizo; Jesús Mosquera
Journal:  Exp Diabetes Res       Date:  2009-10-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.